Trajan Completes Acquisition of SGE Analytical Science

Trajan Completes Acquisition of SGE Analytical Science

May 15, 2013

Trajan Completes Acquisition of SGE Business.

Trajan Scientific and Medical, “Trajan” has completed its acquisition of the Chromatography and Liquid Handling businesses of SGE Analytical Science, “SGE”. SGE was founded by Ern Dawes in Melbourne Australia in 1961 and has remained in the Dawes family for over 50 years. Its business, focussed on components and consumables used in scientific analysis has grown to around 300 staff worldwide with manufacturing operations in Ringwood Australia and subsidiary offices in the USA, Europe and Japan.

Dawes Holdings, the parent company of SGE, owned by Peter Dawes, will retain a range of assets, including the ETP Electron Multiplier business.  Under the new ownership SGE will continue to work closely with ETP and provide global support and distribution services as is the case today.

Trajan, formed in 2011, acquired the pathology consumables business of Grale Scientific, (Victoria Australia) in October 2011.

Trajan’s goal is to bring together a group of leading companies with a common focus in the areas of biological, environmental and food analysis. SGE is an ideal platform for Trajan, with a global footprint and a depth of capability and infrastructure, servicing the leading companies in analytical science’ said Stephen Tomisich CEO of Trajan. 

Under the arrangement Trajan has acquired the manufacturing operations and site in Ringwood Australia, The SGE sites and operations in Europe and the USA and all shareholdings in the SGE subsidiaries located in Europe, the USA and Japan.

We believe that we are in a unique position to serve the current and future needs of people working in the fields of scientific and medical analysis. Specifically we aim to invest in technologies that will deliver more sensitive, selective and more affordable analysis in biological, food and environmental applications. We also intend to fully embrace a global business model where we work with leading companies in the scientific industry to enhance their capacity to deliver solutions in these target areas.

Learn more about Trajan.




Also in News

Interview: Why data quality plays a critical role in personalized medicine, with microsampling expert Dr Michele Protti
Interview: Why data quality plays a critical role in personalized medicine, with microsampling expert Dr Michele Protti

November 30, 2020

Trajan Scientific and Medical’s hemaPEN® microsampling technology has been developed with extensive consultation and evaluation by leading analytical laboratories, clinicians and healthcare professionals.

This month, Trajan presents an exclusive interview with researcher Dr Michele Protti of Pharmaco-Toxicological Analysis, Bologna, Italy, on the future of microsampling and the critical role hemaPEN can play when used in therapeutic drug monitoring for optimal therapy personalization.

Read More

Trajan celebrates International Pathology Day with ScyTek Laboratories to deliver quality IHC solutions
Trajan celebrates International Pathology Day with ScyTek Laboratories to deliver quality IHC solutions

November 11, 2020

In celebration of International Pathology Day, Trajan Scientific and Medical (Trajan) is proud to announce a new partnership with ScyTek Laboratories (ScyTek) to deliver quality immunohistochemistry (IHC) solutions.

Read More

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More